Spring 2024 - BioSupply Trends Quarterly

Spring 2024 - Safety

Share

Up Front

Publisher's Corner

First Do No Harm: Increasing Patient Safety

By Patrick M. Schmidt

Features

Caring for Mental Health in a World of Uncertainty

By Lee Warren

Solving Clinical Trial Delays by Accelerating Patient Recruitment

By Diane L.M. Cook

Mitigating AI Risks for Consumer Health Misinformation

By Amy Scanlin, MS

Improving Patient Safety in the Primary Care Setting

By Rachel Maier, MS

Myths & Facts: Sleep Disorders

By Ronale Tucker Rhodes, MS

Update on Malaria

By Jim Trageser

BioTrends Watch

Washington Report

New Rule Expands Access to Health Information and Improves Prior Authorization Process

CMS Finalizes Rule to Advance Health Equity

$13M NIH Grant Funds Research to Rejuvenate Immune System in Older Adults

New Guidance Recommends All Federal Facilities Have Access to Naloxone

Reimbursement FAQs

Drug Reimbursement: Working with Payers

Healthcare Management

Is Hybrid Care the Future?

Industry News

Discovery Could Predict Immunotherapy Response in Melanoma

Researchers Identify an Immune Cell That Can Attack Cancer

Study Uses Flu Virus to Speed Up COVID-19 Antibodies

Study Will Test Vaccine That Kills Cancer Cells Without Side Effects

Study Shows New Blood Test May Predict Alzheimer’s Risk

First Cancer Patients Receive mRNA Therapy in Clinical Trial

FDA Approves New Safety Labeling for Opioid Medications

Study Shows Patients Vaccinated Against Ebola Are Half as Likely to Die Than Unvaccinated Patients

FDA Approves First Cell Therapy to Treat Melanoma

Third Humira Biosimilar Is Approved by FDA

BioFocus

Industry Insight

Cryoprecipitate, Fibrinogen Concentrates and New Pathogen Reduced Cryo Product Vie for Use in Massive Hemorrhage

By Keith Berman, MPH, MBA

Patient Profile

Anxiety: A Patient’s Perspective

By Trudie Mitschang

Physician Profile

Anxiety: A Physician’s Perspective

By Trudie Mitschang

BioSources

BioResearch

Albumin Administration Superior to Ringer’s Lactate for Maintaining Normovolemia During Major Surgical Hemorrhage

Emicizumab Prophylaxis Efficacious and Well-Tolerated in Infants with Severe Hemophilia A Without Inhibitors